Right to try
The April 2018 issue of Pharmafocus is now live!
March 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Martin Shkreli, Right to try, atrial fibrillation, falsified medicines directive, oncology, opioids, pharma
As we finally pass into Spring after what still feels like a particularly stubborn Winter, we are pleased to announce …
US “right to try” legislation passes after initial defeat
March 22, 2018Medical Communications, Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma
The controversial and much-discussed “right to try” bill has been passed in the US House of Representatives, quickly rebounding after …
Top Ten most popular articles on Pharmafile.com this week
March 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten
Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …
US “right to try” experimental drug bill defeated in House vote
March 14, 2018Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma
The divisive and much-talked-about “right to try” legislation designed to provide access for terminally ill Americans to experimental and unproven …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
